Volgen
Mukul Kelkar
Mukul Kelkar
Senior Scientist, Aurobindo Pharma USA
Geverifieerd e-mailadres voor umaryland.edu
Titel
Geciteerd door
Geciteerd door
Jaar
Formulation and evaluation of solid dispersions of furosemide in sodium starch glycolate
G Chaulang, P Patel, S Hardikar, M Kelkar, A Bhosale, S Bhise
Tropical Journal of Pharmaceutical Research 8 (1), 43-51, 2009
1072009
Androgen-dependent hypertension is mediated by 20-hydroxy-5, 8, 11, 14-eicosatetraenoic acid–induced vascular dysfunction: role of inhibitor of κB kinase
CC Wu, J Cheng, FF Zhang, KH Gotlinger, M Kelkar, Y Zhang, JL Jat, ...
Hypertension 57 (4), 788-794, 2011
622011
Effervescent aerosols: a novel formulation technology for pressurized metered dose inhalers
MS Kelkar, RN Dalby
Respiratory Drug Delivery. River Grove, IL: Davis Healthcare International …, 2014
102014
Formulation of suspension-type pressurized metered dose inhalers using effervescent aerosol technology
MS Kelkar, RN Dalby
Respiratory Drug Delivery Europe 2015 2, 493-496, 2015
22015
Androgen-dependent hypertension is mediated by 20-hete-induced vascular dysfunction: Role of inhibitor kappaB kinase
CC Wu, J Cheng, FF Zhang, KH Gottlinger, M Kelkar, Y Zhang, JL Jat, ...
Hypertension 57, 788-794, 2011
22011
Plume Geometry Evaluation of Solution-type Metered Dose Inhalers Formulated Using Effervescent Aerosol Technology
MS Kelkar, RN Dalby
Respiratory Drug Delivery 2016 3, 579-582, 2016
2016
Effervescent Aerosols: A Novel Formulation Technology for Solution and Suspension-Type Metered Dose Inhalers
MS Kelkar
University of Maryland, Baltimore, 2016
2016
In vitro Delivery Efficiency of Valved Holding Chambers with or without Facemasks
Z Xu, M Kelkar, D von Hollen, A Viswanath, K Nikander, R Dalby
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 27 (4), A19-A20, 2014
2014
Formulation of solution-type pressurized metered dose inhalers using effervescent aerosol technology
MS Kelkar, RN Dalby
Respiratory Drug Delivery Asia 2014, 229-232, 2014
2014
20-HETE Mediates Vascular Remodeling in the Model of Androgen-Induced Hypertension: Role of Hydralazine
Y Liu, CC Wu, M Kelkar, V Garcia, KH Gotlinger, ML Schwartzman
HYPERTENSION 58 (5), E86-E86, 2011
2011
Hydralazine prevents androgen-induced hypertension by inhibiting 20- HETE synthesis
M Kelkar, W CC, G KH, S ML
Winter Eicosanoid Conference, Baltimore, Maryland, 2011
2011
Androgen-dependent and independent 20-HETE-mediated hypertension
WCC Cheng J, Mei S, Zhang FF, Sodhi K, Kelkar M, Capdevila JH, Falck JR ...
Winter Eicosanoid Conference, Baltimore, Maryland, 2011
2011
Androgen-Dependent and Androgen-Independent Increases in CYP4a12 Causes 20-HETE-Mediated Hypertension
CC Wu, J Cheng, S Mei, FF Zhang, K Sodhi, M Kelkar, JH Capdevila, ...
HYPERTENSION 56 (5), E146-E146, 2010
2010
Androgen-Dependent Hypertension is Mediated by 20-Hete-Induced Vascular Dysfunction: Role of Ikappab Kinase
CC Wu, J Cheng, FF Zhang, KH Gotlinger, M Kelkar, JR Falck, ...
HYPERTENSION 56 (5), E93-E93, 2010
2010
Cyp4a12 Transgenic Mice Develop 20-HETE-Dependent hypertension
WCC Schwartzman ML, Cheng J, Mei S, Zhang FF, Sodhi K, Kelkar M, Capdevila ...
Keystone Symposia – Bioactive Lipids: Biochemistry and Diseases, Kyoto, Japan, 2010
2010
Cyp4a12 Transgenic Mice Develop 20-HETE-Dependent hypertension
WCC Schwartzman ML, Cheng J, Mei S, Zhang FF, Sodhi K, Kelkar M, Capdevila ...
Winter Eicosanoid Conference; Baltimore, Maryland, 2010
2010
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–16